Curebase

Curebase identified a critical bottleneck in clinical research: the fragmented, outdated technology infrastructure forcing sponsors and sites to cobble together incompatible systems for patient recruitment, consent, data collection, and engagement. ​​‌‌‌‌‌‌‌​‌‌​​‌​​​​​​‌‌​‌‌‌​​​‌‌This problem hit hardest for mid-sized pharmaceutical companies and contract research organizations managing multiple concurrent trials across distributed sites, where manual coordination and paper-based processes created delays, data errors, and poor participant retention. The inefficiency was measurable—trials routinely missed enrollment targets by 20-30% and took months longer than planned. Before Curebase, alternatives included legacy eClinical platforms like Medidata and Oracle Health Sciences, which were expensive, inflexible, and required extensive customization. Early validation came through direct conversations with trial sponsors struggling with enrollment timelines and site coordinators drowning in administrative work. When Curebase demonstrated how integrated AI-powered tools could streamline participant workflows and automate data capture, sponsors immediately recognized the potential to compress trial timelines and reduce costs, validating the core insight that modern software could fundamentally reshape how clinical research operates.